MA39899A - Utilisation de sécoïsolaricirésinol diglucosides (sdg) et composés associés pour la protection contre le rayonnement et les dommages chimiques - Google Patents
Utilisation de sécoïsolaricirésinol diglucosides (sdg) et composés associés pour la protection contre le rayonnement et les dommages chimiquesInfo
- Publication number
- MA39899A MA39899A MA039899A MA39899A MA39899A MA 39899 A MA39899 A MA 39899A MA 039899 A MA039899 A MA 039899A MA 39899 A MA39899 A MA 39899A MA 39899 A MA39899 A MA 39899A
- Authority
- MA
- Morocco
- Prior art keywords
- sdg
- protection against
- related compounds
- chemical damage
- against radiation
- Prior art date
Links
- PUETUDUXMCLALY-HOTGVXAUSA-N (-)-secoisolariciresinol Chemical compound C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 PUETUDUXMCLALY-HOTGVXAUSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- OGFXBIXJCWAUCH-UHFFFAOYSA-N meso-secoisolariciresinol Natural products C1=2C=C(O)C(OC)=CC=2CC(CO)C(CO)C1C1=CC=C(O)C(OC)=C1 OGFXBIXJCWAUCH-UHFFFAOYSA-N 0.000 title 1
- 230000005855 radiation Effects 0.000 title 1
- 235000004239 secoisolariciresinol Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462005330P | 2014-05-30 | 2014-05-30 | |
| US201562101296P | 2015-01-08 | 2015-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA39899A true MA39899A (fr) | 2021-05-26 |
Family
ID=54700083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA039899A MA39899A (fr) | 2014-05-30 | 2015-06-01 | Utilisation de sécoïsolaricirésinol diglucosides (sdg) et composés associés pour la protection contre le rayonnement et les dommages chimiques |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3148560A4 (ko) |
| JP (2) | JP2017520620A (ko) |
| KR (1) | KR20170010019A (ko) |
| CN (2) | CN112336736A (ko) |
| AU (2) | AU2015266614A1 (ko) |
| CA (1) | CA2950744A1 (ko) |
| IL (1) | IL249219A0 (ko) |
| MA (1) | MA39899A (ko) |
| WO (1) | WO2015184441A2 (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3026950A1 (en) * | 2016-06-07 | 2017-12-14 | Melpo Christofidou-Solomidou | Compositions and methods for protecting organs from ischemia/reperfusion injury associated with transplantation |
| CA3058943C (en) | 2017-04-03 | 2023-10-17 | Gusto Global, Llc | Rational design of microbial-based biotherapeutics |
| US20200268779A1 (en) * | 2017-09-27 | 2020-08-27 | The Trustees Of The University Of Pennsylvania | USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION-INDUCED CARDIOVASCULAR DYSFUNCTION |
| US20210128596A1 (en) * | 2017-09-27 | 2021-05-06 | University Of Pennsylvania | Compositions and methods for treating septic cardiomyopathy |
| WO2020046476A1 (en) * | 2018-08-31 | 2020-03-05 | Innophos, Inc. | Botanical antioxidants |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6486126B1 (en) * | 1999-06-30 | 2002-11-26 | University Of Saskatchewan Technologies Incorporated | Antioxidant activity in SDG metabolites |
| AU2001271296A1 (en) * | 2000-06-14 | 2001-12-24 | Alla Shapiro | Radioprotective agents |
| CN100365005C (zh) * | 2006-03-02 | 2008-01-30 | 江南大学 | 一种从亚麻籽中提取纯化开环异落叶松树脂酚二葡萄糖苷的方法 |
| US20070293458A1 (en) * | 2006-06-16 | 2007-12-20 | Ip-6 Research Inc. | Prevention of nuclear, solar, and other radiation-induced tissue damage |
| WO2008147563A1 (en) * | 2007-05-25 | 2008-12-04 | The Trustees Of The University Of Pennsylvania | Flaxseed lignan complex, methods of using and compositions thereof |
| US8951527B2 (en) * | 2008-08-07 | 2015-02-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Radioprotectants targeting thrombospondin-1 and CD47 |
| CN101759731B (zh) * | 2008-12-25 | 2011-10-19 | 中国科学院兰州化学物理研究所 | 亚麻籽胶和开环异落叶松树脂酚二葡萄糖苷的提取方法 |
| JP6321788B2 (ja) * | 2013-06-10 | 2018-05-09 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | （ｓ，ｓ）−セコイソラリシレジノールジグルコシド及び（ｒ，ｒ）−セコイソラリシレジノールジグルコシドの製造 |
-
2015
- 2015-06-01 AU AU2015266614A patent/AU2015266614A1/en not_active Abandoned
- 2015-06-01 CA CA2950744A patent/CA2950744A1/en not_active Abandoned
- 2015-06-01 EP EP15799095.3A patent/EP3148560A4/en not_active Withdrawn
- 2015-06-01 MA MA039899A patent/MA39899A/fr unknown
- 2015-06-01 WO PCT/US2015/033501 patent/WO2015184441A2/en active Application Filing
- 2015-06-01 JP JP2017515874A patent/JP2017520620A/ja active Pending
- 2015-06-01 CN CN202010760162.0A patent/CN112336736A/zh active Pending
- 2015-06-01 KR KR1020167037042A patent/KR20170010019A/ko unknown
- 2015-06-01 CN CN201580028874.0A patent/CN107155304A/zh active Pending
-
2016
- 2016-11-27 IL IL249219A patent/IL249219A0/en unknown
-
2020
- 2020-04-06 JP JP2020068332A patent/JP2020121987A/ja active Pending
- 2020-11-16 AU AU2020270469A patent/AU2020270469A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3148560A2 (en) | 2017-04-05 |
| CN107155304A (zh) | 2017-09-12 |
| IL249219A0 (en) | 2017-02-28 |
| WO2015184441A3 (en) | 2016-03-10 |
| AU2020270469A1 (en) | 2020-12-17 |
| AU2015266614A1 (en) | 2016-12-15 |
| EP3148560A4 (en) | 2018-04-25 |
| JP2017520620A (ja) | 2017-07-27 |
| WO2015184441A2 (en) | 2015-12-03 |
| CN112336736A (zh) | 2021-02-09 |
| CA2950744A1 (en) | 2015-12-03 |
| WO2015184441A9 (en) | 2016-01-21 |
| JP2020121987A (ja) | 2020-08-13 |
| KR20170010019A (ko) | 2017-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2558826B (en) | Mitigation of anti-sandbox malware techniques | |
| DK3119762T3 (da) | Benzimidazol-derivater som erbb-tyrosin-kinase-inhibitorer til behandlingen af kræft | |
| DK3256853T3 (da) | Forudsigelse af t-celleepitoper, der er egnede til vaccination | |
| EP3161714A4 (en) | Mitigation of malware | |
| DK3466432T3 (da) | Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner | |
| MA46373A (fr) | Composés utilisés comme modulateurs de ror gamma | |
| DK3148529T3 (da) | Forbindelser til behandling af hjernecancer | |
| DK3160927T3 (da) | Fremgangsmåde til fremstilling af ethylenglycol ud fra sukker | |
| SG11201702807YA (en) | Thermal compensation for burst-mode laser wavelength drift | |
| PL3288532T3 (pl) | Polimery do stabilizacji związków nadtlenkowych | |
| BR112016029361A2 (pt) | novos compostos substituídos por halogênio | |
| DK3180329T3 (da) | Triazoler som nr2b receptorinhibitorer | |
| DK3360117T3 (da) | Fremgangsmåde til overvågning af overensstemmelse af personligt sikkerhedsudstyr | |
| MA39899A (fr) | Utilisation de sécoïsolaricirésinol diglucosides (sdg) et composés associés pour la protection contre le rayonnement et les dommages chimiques | |
| MA49623A (fr) | Composés chimiques | |
| EP3314509A4 (en) | Mitigation of malware | |
| DK2921050T3 (da) | Fremgangsmåde til udbringning af plantebeskyttelsesmidler | |
| DK3662925T3 (da) | Sammensætning, der omfatter fsh, til behandling af infertilitet | |
| DK3347307T3 (da) | Fremgangsmåde til ekstraktionen af silikat | |
| DK3144345T3 (da) | Fremgangsmåde til termisk nedbrydning af organiske stoffer | |
| DK3137102T3 (da) | Apc til anvendelse til behandling af unormal kutan ardannelse | |
| DK3171926T3 (da) | Sikkerhedskonnektor til medicinske indretninger | |
| GB2543602B (en) | Mitigation of anti-sandbox malware techniques | |
| ITUB20154000A1 (it) | Dispositivo di protezione per serratura | |
| LT3489849T (lt) | Įėjimo į sistemą procesų apsauga |